Richard Moscicki served as an Executive Vice President of Science and Regulatory Advocacy and Chief Medical Officer at PhRMA, bringing his over 25 years of experience in the pharmaceutical industry to our executive committee. Previously, Dr. Moscicki worked as the Deputy Center Director for Science Operations at the FDA’s Center for Drug Evaluation and Research (CDER), where he provided executive leadership in overseeing the development, implementation and management of CDER’s programs. Prior to the FDA, he was Chief Medical Officer at Genzyme Corporation where he was responsible for worldwide clinical development, regulatory, and pharmacovigilance. He previously served as staff and faculty at Massachusetts General Hospital. Dr. Moscicki is board certified in internal medicine, diagnostic and laboratory immunology, and allergy and immunology. He received his medical degree from Northwestern University Medical School.
